News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
184 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17555)
Month
January (3218)
February (3391)
March (3462)
April (3660)
May (4667)
June (3468)
July (2307)
August (2524)
September (2745)
October (3357)
November (3389)
December (2298)
Day
1 (15)
2 (105)
3 (184)
4 (160)
5 (95)
6 (86)
9 (195)
10 (158)
11 (164)
12 (134)
13 (88)
16 (146)
17 (115)
18 (154)
19 (154)
20 (84)
23 (128)
24 (33)
25 (4)
26 (8)
27 (6)
29 (16)
30 (34)
31 (32)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
9
10
11
12
13
16
17
18
19
20
23
24
25
26
27
29
30
31
Press Releases
NLS Pharmaceutics Announces Promising Preclinical Data for First-in-Class Non-Sulfonamide, Dual Orexin Receptor Agonists for the Potential Treatment of Narcolepsy and Neurological Disorders
December 3, 2024
·
5 min read
Press Releases
Revelation Biosciences Inc. Announces Exercise of Warrants for $4 Million in Gross Proceeds
December 3, 2024
·
5 min read
Press Releases
TRIO Pharmaceuticals Completes $3.1 Million Financing Round to Advance Cancer Therapeutics Pipeline
December 3, 2024
·
4 min read
Press Releases
ShiraTronics Initiates IDE Pivotal Study of Implantable Neuromodulation Therapy for Chronic Migraine
December 3, 2024
·
6 min read
Press Releases
Dermata Completes Enrollment in First Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acne
December 3, 2024
·
6 min read
Press Releases
Saghmos Therapeutics Announces Presentation at the Citi Global Healthcare Conference
December 3, 2024
·
2 min read
Press Releases
Pivot Bio Appoints Melih Keyman to Board of Directors
December 3, 2024
·
3 min read
Press Releases
Kiromic BioPharma Announces Settlement of Previously Disclosed SEC Investigation
December 3, 2024
·
1 min read
Press Releases
First Patient Treated with Adaptimmune’s TECELRA(R) (afamitresgene autoleucel)
December 3, 2024
·
10 min read
Press Releases
Janux Therapeutics Announces Proposed Public Offering
December 3, 2024
·
4 min read
Previous
6 of 19
Next